Moderator: Chris Steyn, MD
90. Impact of patient-controlled analgesia on clinical outcomes after posterior lumbar spinal fusion surgery
Corey Walker, MD1; Arpan A. Patel, BS2; Jakub Godzik, MD3; Juan S. Uribe, MD1; Jay D. Turner, MD, PhD4
1Barrow Neurological Institute, Phoenix, AZ, US; 2University of Arizona College of Medicine - Phoenix, Phoenix, AZ, US; 3Phoenix, AZ, US; 4Barrow Brain and Spine, Phoenix, AZ, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
91. Can the proposed posterior ligament-bone injury classification and severity score predict the failure of anterior-only surgery for subaxial cervical facet dislocations?
Jun-Song Yang, MD1; Ding-Jun Hao, MD1; Tuan-Jiang Liu, MD2; Chen Hao, MD3
1Department of Spine Surgery, Honghui Hospital, Xi'an Jiaotong University, Xi'an, China; 2Xi'an, China; 3Ci’an, China
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
92. Timing of postoperative anticoagulant resumption as a predictor of thromboembolic events in spine surgery
Kelsey A. Isbester, BS1; Konrad Knusel, MSc2; Thomas E. Mroz, MD3; Michael P. Steinmetz, MD4
1The Cleveland Clinic, Center for Spine Health Lab, Cleveland, OH, US; 2Case Western Reserve School of Medicine, Cleveland, OH, US; 3Cleveland Clinic Departments of Orthopaedic and Neurological Surgery, Cleveland, OH, US; 4Cleveland Clinic, Cleveland, OH, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
93. Certificate-of-need state laws and elective posterior lumbar fusions: a medicare trends, costs and outcomes analysis
Azeem T. Malik, MBBS1; Frank M. Phillips, MD2; Sheldon Retchin, MD3; Wendy Xu, PhD3; Safdar N. Khan, MD1
1The Ohio State University Wexner Medical Center, Columbus, OH, US; 2Midwest Orthopaedics At Rush, Chicago, IL, US; 3Columbus, OH, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
94. Cost analysis of primary single level lumbar discectomies
Ali Jalali; Richard Nelson, PhD1; Trevor R. Mordhorst, MS, BA2; Chase B. Grover, BS3; Nicholas Spina, MD1; Darrel S. Brodke, MD4; W. Ryan Spiker, MD5
1Salt Lake City, UT, US; 2University of Washington, Seattle, WA, US; 3University of Utah Orthopaedic Center, Salt Lake City, UT, US; 4University Orthopaedic Center, Salt Lake City, UT, US; 5University of Utah Orthopaedics, Salt Lake City, UT, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
95. Clinical observation of the effect of thoracic-lumbar fracture of Ankylosing Spondylitis treated by posterior percutaneous long segmental internal fixation
Nianhu Li, MD1; Zhanwang Xu, MD, PhD1; Ping Jiang, MSc2; Jia Menglong, BA1; Chen Yue, DO3; Liang Ren, MD4
1Ji'nan, Shandong Province, China; 2Shandong University of Traditional Chinese Medicine, Ji Nan, Shan Dong, China; 3Shandong Hospital of Traditional Chinese Medicine, Jinan, Shandong Province, China; 4The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China
FDA Device/Drug Status: percutaneous fixation system (Approved for this indication)
96. Superior facet joint violations in single level minimally invasive vs open transforaminal lumbar inter body fusion: prospective comparative study
Jwalant Y. Patel, MS
Bombay Hospital and Medical Research Center, Mumbai, Maharashtra, India
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
Discussion